A robust meta-analytic approach for evaluating regional treatment effect in a multi-regional clinical trial
- 26 October 2026
- journal article
- research article
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- p. 1-21
Abstract
1. A multi-regional clinical trial (MRCT) under one study protocol is well-accepted in global drug development. MRCT provides a practical way to achieve targeted recruitment in a reasonable time fr...Keywords
This publication has 18 references indexed in Scilit:
- Using Bayesian Dynamic Borrowing to Maximize the Use of Existing Data: A Case-StudyTherapeutic Innovation & Regulatory Science, 2023
- Robust estimates of regional treatment effects in multiregional randomized clinical trials with semiparametric logistic modelPharmaceutical Statistics, 2021
- Bayes shrinkage estimator for consistency assessment of treatment effects in multi‐regional clinical trialsPharmaceutical Statistics, 2021
- On evaluation of consistency in multi-regional clinical trialsJournal of Biopharmaceutical Statistics, 2017
- Robust exchangeability designs for early phase clinical trials with multiple strataPharmaceutical Statistics, 2015
- Empirical shrinkage estimator for consistency assessment of treatment effects in multi‐regional clinical trialsStatistics in Medicine, 2012
- Bridging DiversityPharmaceutical Medicine, 2010
- A Bayesian Approach to Evaluating Regional Treatment Effect in a Multiregional TrialJournal of Biopharmaceutical Statistics, 2009
- Sample Size Allocation to Regions in a Multiregional TrialJournal of Biopharmaceutical Statistics, 2009
- A Reference Bayesian Test for Nested Hypotheses and its Relationship to the Schwarz CriterionJournal of the American Statistical Association, 1995